Dyax Corp (Nasdaq: DYAX) announced the online publication of scientific data for DX-2930, an investigational fully human monoclonal antibody inhibitor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE